New and complex molecules such as oligonucleotides, AAVs, ADC, fragments, vaccines, and others coming down the pipeline are continuing to challenge the downstream purification and recovery process. Companies are looking toward disruptive innovations and creative strategies, including integrated/continuous processing, improvements in upstream perfusion, process integration and optimization, as well as latest advances and breakthroughs in filtration, clarification, capture and purification. Join our Downstream Processing to hear these exciting approaches and share best practices for downstream purification of these new modalities.
Sonja Berensmeier, PhD, Professor, Bioseparation Engineering Group, Mechanical Engineering, Technical University of Munich
Alex Brinkmann, Senior Engineer II, Biopharmaceutical Development, Biogen